Pharmaceutical News: Latest Indian Pharma, Medical & Healthcare Industry News
The Indian pharmaceutical industry is growing at a very fast pace. With its fast growth, it is highly imperative to stay updated with the current news and trends in the market. Brand India Pharma gives you the latest pharmacy related news to help you stay updated. Read the latest pharmaceutical news about different sectors and their strategies in the Indian Pharma News section. Get fresh updates from Pharma companies like Natco, Panacea Biotec, Hamsons. You can bookmark the Indian Pharma News section for the news on pharmaceuticals, drugs and formulations. The Brand India pharmacy news also includes pharmaceutical conference highlights for inquisitive readers.
Sun Pharma has entered into a partnership with International Centre for Genetic Engineering and Biotechnology (ICGEB) to work on dengue vaccine which would be better and affordable than the existing vaccines available in the market.
October 20, 2016: Sun Pharma has entered into a partnership with International Centre for Genetic Engineering and Biotechnology (ICGEB) to w...
The mandatory marketing code for pharma companies would be having strong penal provisions in order to prevent bribing of doctors for prescribing drugs by drug companies.
September 6, 2016: The voluntary code which was applicable till June 2015 has been allotted four extensions.
The Directorate General of Foreign Trade has laid down the conditions for import and export of human biological samples for commercial purposes recently.
August 12, 2016: As per the policy,
Lupin Ltd, India's third largest drug maker, will buy a portfolio of 21 generic brands from Osaka-based Shionogi & Co. Ltd at the cost of US $150 million.
August 3, 2016: The move will help the company to strengthen its presence in the Japanese market, the second largest pharmaceutical market with a size of US$ 110 bn. The acquisition will make Lupin rank sixth among gen...
Five anti diabetes drugs are amongst the top ten selling drugs in the country. Control of non-communicable disease has been one of the greatest challenges for the country. This is a major shift from the earlier trend when the organised retail pharma market was dominated by anti infectives and antibiotics.